Table 1.
Summary of studies employing different EV loading strategies.
| Cargo | Loading Method | Species | Loading Efficiency/Capacity | References |
|---|---|---|---|---|
| Small RNA and Oligonucleotides (miRNA & siRNA) | Electroporation | Bovine, Murine, E. coli, Human | <0.5–62% | [3], [4], [5], [6], [16], [68], [75], [76], [78], [79], [84], [85], [90], [91], [92], [96], [99], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127] |
| Chemical Transfection | Bovine, Human, Murine | NR-30% | [6], [76], [127] | |
| Sonication | Human | NR | [68] | |
| Incubation | Human, Murine | 70–80% | [58], [59], [60], [128] | |
| Small Molecule Drugs | Electroporation | Human, Murine | 0.5–50% | [7], [8], [9], [64], [67], [80], [116], [129] |
| Sonication | Human, Murine | 8–30% | [67], [93], [130], [131], [132] | |
| Incubation | Bovine, Human, Murine | 1–67% | [28], [50], [51], [61], [64], [67], [129], [131], [132], [133] | |
| Thermal Shock | Human | 10–13% | [61], [132] | |
| DNA and Plasmids | Electroporation | Human, Murine | 1.75–20% | [83], [134], [135] |
| Proteins (e.g. Enzymes and Inhibitors) | Electroporation | Bovine, Human | 0.4–0.5% | [81], [82], [136], [137], [138] |
| Incubation | Murine | 5–19% | [54], [139] | |
| Sonication | Murine | 26% | [54], [139] | |
| Thermal Shock | Murine | 15% | [54] | |
| Extrusion | Murine | 22% | [54] | |
| Nanoparticles | Electroporation | Murine | 7% | [63] |
| Sonication | Murine | 19% | [63] | |
| Incubation | Murine | 14–16% | [63] | |
| Thermal Shock | Murine | 9–18% | [63] | |
| Chemical Transfection | Human | NR | [140] | |
| Gene-Editing Complexes | Electroporation | Human | NR | [141] |